Kestra Medical Technologies, Ltd. (KMTS) vs LeMaitre Vascular, Inc. (LMAT)

A side-by-side comparison of Kestra Medical Technologies, Ltd. and LeMaitre Vascular, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KMTS vs LMAT

growth of $100 · dividends reinvested · last 2y
KMTS +29.8% (+13.9%/yr)LMAT -8.9% (-4.6%/yr)KMTS compounded faster over this window
80100120Start $1002026$130$91
KMTS LMAT

KMTS vs LMAT: by the numbers

  • •LMAT is the larger company ($1.82B vs $1.63B market cap).
  • •LMAT is profitable (25.02% net margin) while KMTS runs a net loss (-140.43%).
  • •LMAT pays a dividend (1.17% yield), while KMTS has no payments in the available dividend history.

Metrics side by side

Valuation

MetricKMTSLMAT
P/E ratioN/A28.00
Forward P/EN/A27.78
PEG ratioN/A1.45
P/S ratio15.306.95
P/B ratio7.354.34
EV / EBITDAN/A21.86
FCF yieldN/A4.05%

Profitability

MetricKMTSLMAT
Gross margin53.89%72.90%
Operating margin-134.48%29.46%
Net margin-140.43%25.02%
ROE-67.40%15.62%
ROIC-47.99%9.81%

Dividends

MetricKMTSLMAT
Dividend yieldN/A1.17%
Payout ratioN/A33.33%

Growth (annualized)

MetricKMTSLMAT
Revenue CAGR (5Y)N/A11.76%
EPS CAGR (5Y)N/A19.42%
FCF CAGR (5Y)N/A13.06%
Total return CAGR (5Y)N/A9.79%

Frequently asked

Does KMTS or LMAT pay a bigger dividend?
LMAT pays a dividend (1.17% yield), while KMTS has no payments in the available dividend history.
Is KMTS or LMAT more profitable?
LMAT runs the higher net margin — KMTS at -140.43% versus LMAT at 25.02%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.